Hong Kong Exchanges and Clearing : YELLOW APPLICATION FORM

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System

("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行 的香港發售股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投 資者戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

✄

	This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company")
	dated 12 September 2019 (the "Prospectus").
	本申請表格使用上海復宏漢霖生物技術股份有限公司（「本公司」）於二零一九年九月十二日刊發的招股章程（「招股章程」）所
Staple your	界定的詞彙。
Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong
payment here	Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the
United States without registration or an exemption from registration under the U.S. Securities Act.
請將股款	本申請表格及招股章程概不構成在香港以外司法權區要約出售或游說要約購買香港發售股份。若無根據美國證券法登記或豁
免登記，香港發售股份不得在美國提呈發售或出售。
緊釘在此	This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner
whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction.
	在任何根據當地法例不得發送、派發或複製本申請表格及招股章程的司法權區內概不得發送或派發或複製（不論方式，也不
	論全部或部分）本申請表格及招股章程。
	Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the
	Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies"
	section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by
		版

Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.

招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件－送呈公司註冊處處長文件」一節所 述其他文件已遵照香港法例第32 章公司（清盤及雜項條文）條例第342C 條的規定，送呈香港公司註冊處處長登記。香港交易 及結算所有限公司、香港聯合交易所有限公司（「聯交所」）、香港中央結算有限公司（「香港結算」）、香港證券及期貨事務監 察委員會（「證監會」）及香港公司註冊處處長對此等文件的內容概不負責。

proceduresSamplein this Application Form and the Prospectus. 還）

Shanghai H nlius Biot ch, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(A joint stock company incorporated in the P op 's R public of China with limited liability)
（於中華人民共和國註冊成立的股份有限公司）
Stock Code	:	2696
股份代號	:	2696
Maximum Offer Price		樣
: HK$57.80 per Offer Share, plus brokerage fee of
		1%, SFC transaction levy of 0.0027% and Stock
		Exchange trading fee of 0.005% (payable in full
		on application in Hong Kong dollars, subject to
		refund)
最高發售價	:	每股發售股份57.80 港元，另加1% 經紀佣金、
		0.0027% 證監會交易徵費及0.005% 聯交所交
		易費（須於申請時以港元繳足，多繳款項可予退

You should re d this Applic tion Form in conjunction with the Prospectus, which contains further inform tion on the pplic tion procedures.

招股章程尚有關於申請程序的其他資料，本申請表格應與招股章程一併閱讀。

Application Form 申請表格
To: h ngh i Henlius Biotech, Inc.	致： 上海復宏漢霖生物技術股份有限公司
Joint ponsors	聯席保薦人
Joint Global Coordinators	聯席全球協調人
Joint Representatives	聯席代表
Joint Bookrunners	聯席賬簿管理人
Hong Kong Underwriters	香港包銷商
Applicants' declaration	申請人聲明
I/We agree to the terms and conditions and application
	本人╱吾等同意本申請表格及招股章程的條款及條件以及
Please refer to the "Effect of completing and submitting	申請程序。見本申請表格「填交本申請表格的效用」一節。
this Application Form" section of this Application Form.
Warning: Only one application may be made for the	警告：任何人士只限作出一次為其利益而進行的申請（惟
benefit of any person(other than an application made	(i) 以合資格復星國際股東身份於橙色申請表格或通過
in the capacity as (i) a Qualifying Fosun International
www.eipo.com.hk 透過橙表eIPO 服務或(ii) 以合資格復星
Shareholder on the ORANGE Application Form or
through the Orange Form eIPO service via www.eipo.	醫藥H 股股東身份於藍色申請表格或通過www.eipo.com.
com.hk or (ii) a Qualifying Fosun Pharma H Shareholder	hk 透過藍表eIPO 服務提出的申請除外）。請參閱「填交本
on the BLUE Application Form or through the Blue	申請表格的效用」一節最後四點。
Form eIPO service via www.eipo.com.hk). Please refer
to the last four bullets of "Effect of completing and
submitting this Application Form" section.

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant 如 閣下欲以香港中央結算（代理人）有限公 司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中 央結算系統」），以記存於 閣下的中央結算系統投資者戶口持有人股份戶口或 閣下指定的中央結 算系統參與者股份戶口，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign):	For Broker use 此欄供經紀填寫	Lodged by 遞交申請的經紀
由（所有）申請人簽署（所有聯名申請人必須簽署）：
	Broker No. 經紀號碼		Broker's Chop 經紀印章
Date: 日期:	╱	╱
D 日	M 月	Y 年
Number of Hong Kong Offer Shares applied for (not more than
3,234,800 H Shares)
			Cheque/banker's cashier order number 支票╱銀行本票號碼
申請香港發售股份數目（不超過3,234,800 股H 股）
				Name of bank on which cheque/banker's cashier order is drawn
Total amount 總額				(see "How to make your application" section) 兌現支票╱銀
			行本票的銀行名稱（見「申請手續」一節）
HK$		港元
Name in English (in BLOCK letters) 英文姓名╱名稱（正楷）
Family name or company name 姓氏或公司名稱	Forename(s) 名字	版
Name in Chinese 中文姓名╱名稱
Family name or company name 姓氏或公司名稱	For nam (s) 名字
Occupation in English 職業（以英文填寫）			Hong Kong Id ntity Card No./Passport No./Hong Kong Business
				R gistration No.* (Please delete as appropriate) 香港身份證號碼╱
				護照號碼╱香港商業登記號碼*（請刪除不適用者）
					樣
Names of all other joint applicants in English (if any, in BLOCK etters)
Hong Kong Identity Card No./Passport No./Hong Kong Business
所有其他聯名申請人的英文姓名╱名稱（如有，正楷）	Registration No. of all other joint applicants* (Please delete as
				appropriate) 所有其他聯名申請人的香港身份證號碼╱護照號
1)				碼╱香港商業登記號碼*（請刪除不適用者）
2)				1)
			2)
3)
			3)

	Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant
	only, in BLOCK letters) 香港地址（以英文正楷填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼）
	Sample
		Telephone No. 電話號碼
	For Nominees: You will be tre ted s applying for your own
benefit if you do not complete this section. Please provide an		THIS BOX MUST BE DULY COMPLETED
account number or identific tion code for each (joint) beneficial		必須填妥此欄
owner. 由代名人遞交：代名人若不填寫本節，是項認購申請
	Participant I.D. of the CCASS Investor Participant or designated
	將視作為 閣下利益提出。請填寫每名（聯名）實益擁有人的
		CCASS Participant 中央結算系統投資者戶口持有人或指定的中
	賬戶號碼或識別編碼。
		央結算系統參與者的參與者編號
	ADDRESS LABEL 地址標貼 (Your name(s) and address in		For designated CCASS Participant or Corporate CCASS Investor
Hong Kong in BLOCK letters 請用英文正楷填寫姓名╱名稱及		Participant, please also affix the company chop bearing its company
香港地址）		name 指定的中央結算系統參與者或中央結算系統公司投資者戶
			口持有人，請加蓋顯示公司名稱的公司印鑑

For Internal use 此欄供內部使用

(See paragraph 2 in the section "How to make your application") （請參閱「申請手續」一節第2 段）

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant 如 閣下欲以香港中央結算（代理人）有限公 司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中 央結算系統」），以記存於 閣下的中央結算系統投資者戶口持有人股份戶口或 閣下指定的中央結 算系統參與者股份戶口，請使用本表格

*(1)	If you are a CCASS Investor Participant, only a Hong Kong Identity Card number (if you are an individual) or a Hong
	Kong Business Registration number (if you are a body corporate) will be accepted for this application, please see
	paragraph 2 under the section "How to make your application".
	如	閣下為中央結算系統投資者戶口持有人，是項申請僅接納香港身份證號碼（如屬個別人士）或香港商
	業登記號碼（如屬法人團體）；請參閱「申請手續」一節第2 段。	版
(2)	If you are applying through a designated CCASS Participant (other than a CCASS Investor Participant): For an
	individual, you must provide your Hong Kong Identity Card number or passport number. If you hold a Hong Kong
	Identity Card, please provide that number. If you do not hold a Hong Kong Identity Card, please provide your passport
	number. For a body corporate, please provide your Hong Kong Business Registration number.
	如	閣下透過中央結算系統投資者戶口持有人以外的指定中央結算系統參與者提出申請：如屬個別人
	士，必須填寫 閣下的香港身份證號碼或護照號碼（持有香港身份證者請填寫香港身份證號碼，否則請填
	寫護照號碼）；如屬法人團體，請填寫香港商業登記號碼。
			樣
(3)	Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the first-named applicant
	may be printed on your refund cheque (if any). Such data will be used for checking the validity of Application Form
	and such data would also be transferred to a third party for such purpose and refund purpose. Your banker may require
	verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque.
	日後如需退回申請股款，退款支票上或會印有	閣下或（如屬聯名申請人）排名首位申請人的香港身份
	證號碼╱護照號碼的一部分。有關資料將用於核實申請表格的有效性，亦會轉交第三方作資料核實和退
	款。銀行兌現退款支票前或會要求查證 閣下的香港身份證號碼╱護照號碼。
Sample
(4)	If an application is made by an unlisted company and:
	‧	the principal business of that company is d aling in s curiti s; and
	‧	you exercise statutory control over that company, th n the application will be treated as being made for your
		benefit.
	倘若申請人是一家非上市公司，而：
	‧ 該公司主要從事證券買賣業務；及		閣下的利益提出。
	‧ 閣下對該公司可行使法定控制權，是項申請將視作為
(5)	All joint applicants must give (if they are individua s) th ir Hong Kong Identity Card numbers or, where applicable,
	passport numbers, or (if they are bodies cor orate) their Hong Kong Business Registration numbers.
	所有聯名申請人必須提供（如屬個別人士）其香港身份證號碼或（如適用）護照號碼，或（如屬法人團體）其
	香港商業登記號碼。
Mixed Media Offer	混合媒介要約
The Company will be relying on Section 9A of the	本公司將依據香港法例第32L 章《公司（豁免公司及招
Companies (Exe ption of Co anies and Pros ectuses	股章程遵從條文）公告》第9A 條，在(i) 並非與招股章
from Compliance with Provisions) Notice (Chapter 32L	程印刷本一併發出的情況下，發出白色及黃色申請
of the Laws of Hong Kong) and will be issuing (i) the	表格；及(ii) 並非與招股章程印刷本一併發出的情況
WHITE and YELLOW Application For s without
them being cco p nied by printed Prospectus; and	下，向相關合資格復星國際股東發出橙色申請表格及
(ii) the ORANGE Applic tion For s to the relevant	向相關合資格復星醫藥H 股股東發出藍色申請表格，
Qualifying Fosun Intern tion l Shareholders and the	除非相關合資格復星國際股東或相關合資格復星醫
BLUE Applic tion Forms to the relevant Qualifying Fosun	藥H 股股東（視情況而定）已選擇根據復星國際或復星
Pharma H h reholders without them being accompanied	醫藥（視情況而定）公司通訊政策收取公司通訊印刷
by a printed Prospectus, unless the relevant Qualifying
Fosun Intern tion l h reholders or the relevant Qualifying	本或未被要求選擇收取復星國際或復星醫藥（視情況
Fosun Pharma H hareholders (as the case may be) have	而定）公司通訊稿的方式，在此情況下，招股章程印
elected to receive corporate communications in printed	刷本會分開寄發予彼等。招股章程的印刷本的內容與
form under the corporate communications policy of Fosun	招股章程的電子版本相同，招股章程的電子版本分別
International or Fosun Pharma (as the case may be), or have	在本公司網站www.henlius.com及聯交所網站www.
not been asked to elect the means of receiving the corporate
hkexnews.hk「披露易＞上市公司公告＞最新上市公
communications of Fosun International or Fosun Pharma
司公告」一欄中可供查閱及下載。
(as the case may be), in which case the printed Prospectus
will be despatched to them separately. The contents of the
printed Prospectus are identical to the electronic version
of the Prospectus which can be accessed and downloaded
from the websites of the Company at www.henlius.com
and the Stock Exchange at www.hkexnews.hkunder the
"HKExnews > Listed Company Information > Latest Listed
Company Information" section, respectively.

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant 如 閣下欲以香港中央結算（代理人）有限公 司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中 央結算系統」），以記存於 閣下的中央結算系統投資者戶口持有人股份戶口或 閣下指定的中央結 算系統參與者股份戶口，請使用本表格

Members of the public, the Qualifying Fosun	有意索取招股章程印刷本的公眾人士、合資格
International Shareholders and the Qualifying Fosun	復星國際股東及合資格復星醫藥H 股股東可於
Pharma H Shareholders who wish to obtain a copy	二零一九年九月十二日（星期四）上午九時正至
of the printed Prospectus may obtain a copy, free of	二零一九年九月十七日（星期二）中午十二時正
charge, upon request during normal business hours	的正常辦公時間內，在以下地點免費索取：
from 9:00 a.m. on Thursday, 12 September 2019 until
12:00 noon on Tuesday, 17 September 2019 at the
following locations:
1. any of the following branches of the receiving	1. 本公司收款銀行的下列任何分行：
banks of the Company:		樣
Bank of China (Hong Kong) Limited	中國銀行（香港）有限公司
District	Branch Name	Address	地區	分行名稱	地址
Hong Kong	Des Voeux Road	111-119 Des Voeux Road West,	香港島	德輔道西分行	香港德輔道西111-119號
Island	West Branch	Hong Kong			版
Sample		柴灣分行	香港柴灣道341-343號
	Chai Wan Branch	Block B, Walton Estate, 341-343
		Chai Wan Road, Chai Wan, Hong Kong			宏德居B座
Kowloon	Telford Plaza Branch	Shop Unit P2-P7, Telford P aza,	九龍	德福廣場分行	九龍灣偉業街33號
		No.33 Wai Yip Street, Kow oon Bay,			德福廣場P2-P7號舖
		Kowloon
	Olympian City Branch	Shop 133, 1/F, Olym ian City 2,		奧海城分行	九龍海庭道18號
		18 Hoi Ting Road, Kow oon			奧海城二期一樓133號
New	Metro City Branch	Shop 209, Level 2, Metro City Phase 1,	新界	新都城分行	新界將軍澳
Territories		Tseung Kwan O, New Territories			新都城一期二樓209號
	Ma On Shan	Shop 2103, Level 2, Ma On Shan Plaza,		馬鞍山廣場分行	新界馬鞍山西沙路
	Plaza Branch	Sai Sha Road, Ma On Shan,			馬鞍山廣場L2層2103號
		New Territories
CMB Wing Lung B nk Li ited	招商永隆銀行有限公司
District	Br nch N me	Address	地區	分行名稱	地址
Hong Kong	He d Office	45 Des Voeux Road Central	香港島	總行	德輔道中45號
Island
	Kennedy Town Branch	28 Catchick Street		堅尼地城分行	吉席街28號
Kowloon	Mongkok Branch	B/F CMB Wing Lung Bank Centre,	九龍	旺角分行	彌敦道636號
		636 Nathan Road			招商永隆銀行中心地庫
	Tsim Sha Tsui Branch	4 Carnarvon Road		尖沙咀分行	加拿分道4號
New	Tsuen Wan Branch	251 Sha Tsui Road	新界	荃灣分行	沙咀道251號
Territories

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant 如 閣下欲以香港中央結算（代理人）有限公 司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中 央結算系統」），以記存於 閣下的中央結算系統投資者戶口持有人股份戶口或 閣下指定的中央結 算系統參與者股份戶口，請使用本表格

2. any of the following offices of the below Joint	2. 以下聯席全球協調人的下列任何辦事處：
Global Coordinators:
China International Capital Corporation	中國國際金融香港證券有限公司
Hong Kong Securities Limited	香港			版
29th Floor, One International Finance Centre	中環	號
1 Harbour View Street	港景街1
Central	國際金融中心一期29 樓
Hong Kong
Merrill Lynch (Asia Pacific) Limited	Merrill Lynch (Asia Pacific) Limited
Level 55 Cheung Kong Center	香港
2 Queen's Road Central	樣
中環
Central	皇后大道中2 號
Hong Kong	長江集團中心55 樓
BOCI Asia Limited	中銀國際亞洲有限公司
26th Floor, Bank of China Tower	香港
1 Garden Road	中環	號
Central	花園道1	樓
Hong Kong	中銀大廈26
Sample	UBS AG Hong Kong Branch
UBS AG Hong Kong Branch
52/F, Two International Finance Centre	香港
8 Finance Street	中環	號
Central	金融街8
Hong Kong	國際金融中心二期52 樓
CMB International Capital Limited	招銀國際融資有限公司
45/F, Champion Tower	香港
3 Garden Road	中環	號
Central	花園道3	樓
Hong Kong	冠君大廈45
Fosun Hani Securities Limited	復星恆利證券有限公司
Suite 2101-2105 21/F Cha pion Tower	香港
3 Garden Road	中環	號
Central	花園道3	樓2101-2105室
Hong Kong	冠君大廈21
3. the Depository Counter of HKSCC at 1/F, One	3. 香港結算存管處服務櫃檯，地址為香港中
& Two Exch nge Squ re, 8 Connaught Place,	環康樂廣場	8 號交易廣場一座及二座一樓。
Centr l, Hong Kong.
Details of where printed Prospectuses may be	可索取招股章程印刷本的地址詳情將於派發白
obtained will be displ yed prominently at every	色及黃色申請表格的各個地點以顯眼方式展示。
location where WHITE and YELLOW Application
Forms are distributed.
During normal business hours from 9:00 a.m. on	於二零一九年九月十二日（星期四）上午九時正
Thursday, 12 eptember 2019 until 12:00 noon on	至二零一九年九月十七日（星期二）中午十二時
Tuesday, 17 September 2019, at least three copies of	正的正常辦公時間內，在派發白色及黃色申請
the printed Prospectus will be available for inspection	表格的各個地點（載於招股章程「如何申請香港
at every location where the WHITE and YELLOW	發售股份及預留股份」），均有至少三份招股章
Application Forms are distributed as set out in the	程印刷本可供查閱。	閣下提交本申表格前須
section headed "How to Apply for Hong Kong Offer	閱讀招股章程。
Shares and Reserved Shares" in the Prospectus. You
should read the Prospectus prior to submitting this
Application From.

樣	版
Sample
This page is int ntiona y l ft blank
此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 100 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

NUMBER OF HONG KONG OFFER SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

No. of Hong Kong	Amount payable	No. of Hong Kong	Amount payable	No. of Hong Kong	Amount payable	No. of Hong Kong	Amount payable
Offer Shares	on application	Offer Shares	on application	Offer Shares	on application	Offer Shares	on application
applied for	HK$	applied for	HK$	applied for	HK$	applied for	HK$
100	5,838.25	3,500	204,338.58	70,000	4,086,771.54	2,000,000	116,764,901.20
200	11,676.49	4,000	233,529.80	80,000	4,670,596.05	2,500,000	145,956,126.50
300	17,514.74	4,500	262,721.03	90,000	5,254,420.55	3,000,000	175,147,351.80
400	23,352.98	5,000	291,912.25	100,000	5,838,245.06	3,234,800(1)	188,855,551.20
500	29,191.23	6,000	350,294.70	200,000	11,676,490.12
600	35,029.47	7,000	408,677.15	300,000	17,514,735.18
700	40,867.71	8,000	467,059.60	400,000	23,352,980.24
800	46,705.96	9,000	525,442.06	500,000	29,191,225.30
900	52,544.20	10,000	583,824.51	600,000	35,029,470.36
1,000	58,382.45	20,000	1,167,649.01	700,000	40,867,715.42
1,500	87,573.68	30,000	1,751,473.52	800,000	46,705,960.48
2,000	116,764.90	40,000	2,335,298.02	900,000	52,544,205.54	(1)
版Maximum number of Hong
2,500	145,956.13	50,000	2,919,122.53	1,000,000	58,382,450.60	Kong Offer Shares you may
3,000	175,147.35	60,000	3,502,947.04	1,500,000	87,573,675.90	apply for.
				樣
Sample

2. You, as the applicant(s), must complete the form in English in BLOCK letters as indicated below and sign on the second page of the Application Form. On y writt n signatures will be accepted (and not by way of

personal chop).
If you are applying through a designated CCASS Participant (oth r than a CCASS Investor Participant):
‧	the designated CCASS Participant must	ndorse the form with its company chop (bearing its company
	name) and insert its partici ant I.D. in the a	ro riate box.
If you are applying as an individual CCASS Investor Participant:
‧	the form must contain your NAME and Hong Kong I.D. Card number.
‧	your participant I.D. must be inserted in the a	ropriate box.
If you are applying as a joint individual CCASS Investor Participant:
‧	the form must contain all joint investor	artici ants' NAMES and the Hong Kong I.D. Card number of
‧	all joint investor partici ants;
your participant I.D.	ust be inserted in the appropriate box.
If you are applying as a corporate CCASS Investor Participant:
‧	the form ust contain your co pany NAME and Hong Kong Business Registration number;
‧	your p rticip nt I.D.	nd your co pany chop (bearing your company name) must be inserted in the

ppropri te box.
Incorrect or o	ission of details of the CCASS Participant including participant I.D. and/or company chop
be ring its co	p ny n e or other si ilar atters may render your application invalid.

3. Staple your cheque or b nker's cashier order to the form. Each application for the Hong Kong Offer Shares
	must be ccomp nied by either one separate cheque or one separate banker's cashier order. Your application
	will be rejected if your cheque or banker's cashier order does not meet all the following requirements:
	The cheque must:	Banker's cashier order must:
	• be in Hong Kong dollars;
	• not be post-dated;
	• be made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS
	BIOTECH PUBLIC OFFER";
	• be crossed "Account Payee Only";	• be issued by a licensed bank in Hong Kong, and
	• be drawn on your Hong Kong dollar bank
	account in Hong Kong; and	have your name certified on the back by a person
	• show your account name, which must either be	authorised by the bank. The name on the banker's
	pre-printed on the cheque, or be endorsed on the	cashier order must correspond with your name.
	back by a person authorised by the bank. This	If it is a joint application, the name on the back
	account name must correspond with your name.	of the banker's cashier order must be the same as
	If it is a joint application, the account name must	the first-named applicant's name.
	be the same as the first-named applicant's name.

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

4. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker's cashier order attached) to one of the collection boxes at any of the following branches of Bank of China (Hong Kong) Limited and CMB Wing Lung Bank Limited:

Bank of China (Hong Kong) Limited

District	Branch Name	Address	版
Hong Kong Island	Des Voeux Road West Branch	111-119 Des Voeux Road West, Hong Kong
	Chai Wan Branch	Block B, Walton Estate, 341-343 Chai Wan Road, Chai
		Wan, Hong Kong
Kowloon	Telford Plaza Branch	Shop Unit P2-P7, Telford Plaza, No.33 Wai Yip Street,
		Kowloon Bay, Kowloon
	Olympian City Branch	Shop 133, 1/F, Olympian City 2, 18 Hoi Ting Road,
		Kowloon
New Territories	Metro City Branch	Shop 209, Level 2, Metro City Phase 1, Tseung Kwan
		O, New Territories
	Ma On Shan Plaza Branch	Shop 2103, Level 2, Ma On Shan Plaza, Sai Sha Road,
Sample
		Ma On Shan, New Territories
CMB Wing Lung Bank Limited
District	Branch Name	Addr ss
Hong Kong Island	Head Office	45 D樣s Vo ux Road Central
	Kennedy Town Branch	28 Catchick Street
Kowloon	Mongkok Branch	B/F CMB Wing Lung Bank Centre, 636 Nathan Road
	Tsim Sha Tsui Branch	4 Carnarvon Road
New Territories	Tsuen Wan Branch	251 Sha Tsui Road

5. Your Application Form can be lodged at these times:
Thursd	y, 12	Septe	ber 2019	-	9:00 a.m. to 5:00 p.m.
Frid	y, 13	Septe	ber 2019	-	9:00 a.m. to 5:00 p.m.
Mond	y, 16	September 2019	-	9:00 a.m. to 5:00 p.m.
Tuesd	y, 17	September 2019	-	9:00 a.m. to 12:00 noon

6. The l test time for lodging your application is 12:00 noon on Tuesday, 17 September 2019. The application lists will be opened between 11:45 a.m. to 12:00 noon on that day, subject only to the weather conditions, as described in "D. Effect of Bad Weather on the Opening and Closing of the Application Lists" in the "How to Apply for Hong Kong Offer Shares and Reserved Shares" section of the Prospectus.

The applications for the Hong Kong Offer Shares will commence on Thursday, 12 September 2019 through Tuesday, 17 September 2019. The application monies (including the brokerage fees, SFC transaction levies and Stock Exchange trading fees) will be held by the receiving banks and on behalf of the Company after the closing of the application lists and the refund monies, if any, will be returned to the applicants without interest on or before Tuesday, 24 September 2019. Investors should be aware that the dealings in the H Shares on the Stock Exchange are expected to commence on Wednesday, 25 September 2019.

如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售 股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投資者 戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

申請手續

1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為100 股香港發售股份，並為 下表所列的其中一個數目，否則恕不受理。

				可供申請認購的香港發售股份數目及應繳款項
	申請認購的	申請時	申請認購的	申請時	申請認購的	申請時		申請認購的	申請時
								版
	香港發售	應繳款項	香港發售	應繳款項	香港發售	應繳款項		香港發售	應繳款項
	股份數目	（港元）	股份數目	（港元）	股份數目	（港元）		股份數目	（港元）
		100	5,838.25	3,500	204,338.58	70,000	4,086,771.54		2,000,000	116,764,901.20
		200	11,676.49	4,000	233,529.80	80,000	4,670,596.05		2,500,000	145,956,126.50
		300	17,514.74	4,500	262,721.03	90,000	5,254,420.55		3,000,000	175,147,351.80
		400	23,352.98	5,000	291,912.25	100,000	5,838,245.06		3,234,800(1)	188,855,551.20
		500	29,191.23	6,000	350,294.70	200,000	11,676,490.12
		600	35,029.47	7,000	408,677.15	300,000	17,514,735.18
		700	40,867.71	8,000	467,059.60	400,000	23,352,980.24
		800	46,705.96	9,000	525,442.06	500,000	29,191,225.30
		900	52,544.20	10,000	583,824.51	600,000	35,029,470.36
		1,000	58,382.45	20,000	1,167,649.01	700,000	40,867,715.42
		1,500	87,573.68	30,000	1,751,473.52	800,000	46,705,960.48
	Sample
		2,000	116,764.90	40,000	2,335,298.02	900,000	52,544,205.54
		2,500	145,956.13	50,000	2,919,122.53	1,000,000	58,382,450.60	(1)	閣下可申請認購的香港發售股
		3,000	175,147.35	60,000	3,502,947.04	1,500,000	87,573,675.90		份最高數目。
2.	閣下作為申請人，必須按照下列指示以英文正楷填妥表格，並於申請表格次頁簽署，只接納親
	筆簽名（不得以個人印章代替）。
	如	閣下透過中央結算系統投資者戶口持有人以外的指定中央結算系統參與者提出申請：樣
	‧	該指定中央結算系統參與者必須於表格蓋上公司印鑑（附有公司名稱），並在適當方格內填
		寫參與者編號。
	如	閣下以個人中央結算系統投資者戶口持有人名義提出申請：
	‧	表格須載有 閣下的姓名和香港身份證號碼。
	‧	須在適當方格內填寫 閣下的參與者編號。
	如	閣下以聯名個人中央結算系統投資者戶口持有人名義提出申請：
	‧	表格須載有所有聯名投資者戶口持有人的姓名和香港身份證號碼；
	‧	須在適當方格內填寫 閣下的參與者編號。
	如	閣下以公司中央結算系統投資者戶口持有人名義提出申請：
	‧	表格須載有 閣下的公司名稱和香港商業登記號碼；
	‧ 須在適當方格內填寫 閣下的參與者編號並蓋上公司印鑑（附有公司名稱）。
	中央結算系統參與者的資料（包括參與者編號及╱或顯示公司名稱之公司印鑑）或其他類似事項
	如有不確或遺漏，均可能導致申請無效。
3.	閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須附一張獨立開出支票或一張獨
	立開出銀行本票。支票或銀行本票必須符合以下所有規定，否則有關的認購申請不獲接納：
支票必須：			銀行本票必須：
‧ 為港元；
‧ 不得為期票；
‧ 註明抬頭人為「中國銀行( 香港) 代理人有限公司 － 復宏漢霖生物技術公開發售」；
‧ 劃線註明「只准入抬頭人賬戶」；
‧ 從 閣下在香港的港元銀行賬戶中開出；及	‧ 須由香港持牌銀行開出，並由有關銀行授
‧ 顯示	閣下的賬戶名稱，而該賬戶名稱必須	權的人士在銀行本票背面簽署核證 閣下
	已預印在支票上，或由有關銀行授權的人士	姓名╱名稱。銀行本票所示姓名╱名稱
	在支票背書。賬戶名稱必須與	閣下姓名╱	須與	閣下姓名╱名稱相同。如屬聯名申
	名稱相同。如屬聯名申請，賬戶名稱必須與	請，銀行本票背面所示姓名╱名稱必須與
	排名首位申請人的姓名╱名稱相同。	排名首位申請人的姓名╱名稱相同。

如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售 股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投資者 戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

4. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入下列中國銀行 （香港）有限公司及招商永隆銀行有限公司的任何一家分行特設的收集箱：

	中國銀行（香港）有限公司
	地區	分行名稱	地址			版
	香港島	德輔道西分行	香港德輔道西	111-119號
		柴灣分行	香港柴灣道341-343 號宏德居B 座
	九龍	德福廣場分行	九龍灣偉業街33 號德福廣場 P2-P7 號舖
				樣
		奧海城分行	九龍海庭道18	號奧海城二期一樓133 號
	新界	新都城分行	新界將軍澳新都城一期二樓209 號
		馬鞍山廣場分行	新界馬鞍山西沙路馬鞍山廣場L2 層2103 號
	招商永隆銀行有限公司
	Sample
	地區	分行名稱	地址
	香港島	總行	德輔道中45 號
		堅尼地城分行	吉席街28 號
	九龍	旺角分行	彌敦道636 號招商永隆銀行中心地庫
		尖沙咀分行	加拿分道4 號
	新界	荃灣分行	沙咀道251 號
5.	閣下可於下列時間遞交申請表格：
		二零一九年九月十二日（星期四）－ 上午九時正至下午五時正
		二零一九年九月十三日（星期五）－ 上午九時正至下午五時正
		二零一九年九月十六日（星期一）－ 上午九時正至下午五時正
		二零一九年九月十七日（星期二）－ 上午九時正至中午十二時正
6.	截止遞交申請的時間為二零一九年九月十七日（星期二）中午十二時正。本公司將於當日上午
	十一時四十五分至中午十二時正期間登記認購申請，唯一會影響此時間的變化因素為當日的天
	氣情況（詳見招股章程「如何申請香港發售股份及預留股份」一節「D. 惡劣天氣對開始及截止辦理
	申請登記的影響」）。

香港發售股份申請將會自二零一九年九月十二日（星期四）起直至二零一九年九月十七日（星期 二）止。申請款項（包括經紀佣金、證監會交易徵費及聯交所交易費）將由收款銀行於截止辨理申 請登記後代表本公司持有，且退款金額（如有）將於二零一九年九月二十四日（星期二）或之前不 計利息退還予申請人。投資者務請注意，預期H 股將於二零一九年九月二十五日（星期三）於聯 交所開始買賣。

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

Shanghai Henlius Biotech, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

GLOBAL OFFERING

Conditions of your application

‧

confirm that you have received and read the Prospectus

A.

Who can apply

and

have

only relied

on

the

information and

representations

contained

in the Prospectus

in making your

application and

1.

You and any person(s) for whose benefit you are applying must

will not rely on any other information or representations except

be 18 years of age or older and must have a Hong Kong address.

those in any supplement to the Prospectus;

2.

If

you are

a

firm, the

application

must

be

in the individual

‧

confirm that you are aware of the restrictions on the Global

members' names.

樣

3.

The number of joint applicants may not exceed 4.

‧

Offering in the Prospectus;

4.

If you are a body corporate, the application must be signed

agree that none of the Company, the Relevant Persons and the

by a duly authorised officer, who must state his representative

White Form eIPO Service Provider is or will be liable for any

capacity, and stamped with your corporation's chop.

information and representations not in the Prospectus (and any

5.

You must be outside the United States, not be a United States

‧

supplement to it);

undertake and confirm that you or the person(s) for whose

Person (within the meaning of Regulation S) or a person

benefit you have made the版application have not applied for or

Sample

described in paragraph (h)(3) of Rule 902 of Regulation S and

taken up, or indicated an interest for, and will not apply for

not be a legal or natural person of the PRC (except qualified

or take up, or indicate an interest for, any Offer Shares under

domestic institutional investors).

the Int rnational Offering nor participated in the International

6.

Unless permitted by the Listing Rules

and

guidance l tt rs

Off ring;

issued by the Stock Exchange, or any relevant waivers that have

‧

agr

to

disclose to

the

Company, the H Share Registrar,

been granted by the Stock Exchange, you cannot app y for any

r c iving

banks and

the

Relevant Persons any personal data

Hong Kong Offer Shares if you are:

which th y may require about you and the person(s) for whose

‧ an existing beneficial owner of shares in the Company

b n fit you have made the application;

‧

and/or any of its subsidiaries ;

‧

if the laws of any place outside Hong Kong apply to your

a director or chief executive officer of the Com any and/

application, agree and warrant that you have complied with

or any of its subsidiaries;

a l such laws and none of the Company nor the Relevant

‧ an associate of any of the above;

Persons will breach any law outside Hong Kong as a result of

‧

a connected person of the Com any or will become a

the acceptance of your offer to purchase, or any action arising

connected person of the Com any immediately u on

from your rights and obligations under the terms and conditions

‧

completion of the Global Offering; or

contained in the Prospectus and this Application Form;

have

been

allocated

or

have a

lied

for

or indicated

‧

agree that once your application has been accepted, you may

an interest

in any Offer

Shares under

the

International

not rescind it because of an innocent misrepresentation;

Offering (except in respect of Reserved Shares applied for

‧

agree that your application will be governed by the laws of

pursuant to the Preferential Offering).

Hong Kong;

B.

If you re

no

inee

‧

represent, warrant and undertake that (i) you understand

You, as

nominee,

y

ke

ore than one application for the

that the Hong Kong Offer Shares have not been and will not

Hong Kong Offer Sh res by: (i) giving electronic instructions to

be registered under the U.S. Securities Act; and (ii) you and

HKSCC via Centr l Cle ring

nd Settle

ent System ("CCASS") (if

any person for whose benefit you are applying for the Hong

you are a CCASS P rticip nt); or (ii) using a WHITE or YELLOW

Kong Offer Shares are outside the United States (as defined in

Application Form,

nd lodge more th n one application in your own

Regulation S) or are a person described in paragraph (h)(3) of

name on beh lf of different benefici l owners.

Rule 902 of Regulation S;

C.

Effect of completing nd submitting this Application Form

‧ warrant that the information you have provided is true and

accurate;

By completing and submitting this Application Form, you (and if you

‧

agree to accept the Hong Kong Offer Shares applied for, or any

are joint applicants, each of you jointly and severally) for yourself or

lesser number allocated to you under the application;

as an agent or a nominee on behalf of each person for whom you act:

‧

authorise the Company to place the name of the HKSCC

‧

undertake to execute all relevant documents and instruct and

Nominees on the Company's register of members as the

authorise the Company and/or the Joint Representatives (or their

holder(s) of any Hong Kong Offer Shares allocated to you, and

agents or nominees), as agents of the Company, to execute any

the Company and/or its agents to deposit any Share certificate(s)

documents for you and to do on your behalf all things necessary

into CCASS and/or to send any refund cheque(s) to you or the

to register any Hong Kong Offer Shares allocated to you in

first-named applicant for joint application by ordinary post at

the name of HKSCC Nominees as required by the Articles of

your own risk to the address stated on the application, unless

‧

Association;

you have fulfilled the criteria set out in "Personal Collection" in

agree to comply with the Companies Ordinance (Chapter 622

the "How to Apply for Hong Kong Offer Shares and Reserved

of the Laws of Hong Kong), the Companies (Winding Up and

Shares" section of the Prospectus to collect refund cheque(s) in

Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws

person;

‧

of Hong Kong) and the Articles of Association;

‧

agree that the shares to be allotted shall be issued in the name

confirm that you have read the terms and conditions and

of HKSCC Nominees and deposited directly into CCASS for

application procedures set out in the Prospectus and in this

credit to your investor participant stock account or the stock

Application Form and agree to be bound by them;

account of your designated CCASS Participant;

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

‧ agree that each of HKSCC and HKSCC Nominees reserves the	Hong Kong business registration numbers of successful applicants
	right (1) not to accept any or part of such allotted shares issued	under the Hong Kong Public Offering and the Preferential Offering
	in the name of HKSCC Nominees or not to accept such allotted	(where applicable) will be available on the above websites.
	shares for deposit into CCASS; (2) to cause such allotted shares	If your application for Hong Kong Offer Shares is successful (in
	to be withdrawn from CCASS and issued in your name at your
	whole or in part)
	own risk and costs; and (3) to cause such allotted shares to be
	If your application is	wholly or	partially successful, your Share
	issued in your name (or, if you are a joint applicant, to the first-
	certificate(s) (subject	to their	becoming valid certificates of
	named applicant) and in such a case, to post the certificates for
	title provided that the Hong Kong Public Offering has become
	such allotted shares at your own risk to the address on your
	unconditional and not	having been terminated at 8:00 a.m. on
	application form by ordinary post or to make available the same
	Wednesday, 25 September 2019) will be issued in the name of
	for your collection;
‧								HKSCC Nominees and deposited directly into CCASS for credit to
agree that each of HKSCC and HKSCC Nominees may adjust
	the number of allotted shares issued in the name of HKSCC	your CCASS Investor Participant stock account or the stock account
	of your designated CCASS Participant as instructed by you in your
	Nominees;
‧								Application Form on Tuesday, 24 September 2019 or, in the event of
agree that neither HKSCC nor HKSCC Nominees shall have
	any liability for the information and representations not so	a contingency, on any other date as shall be determined by HKSCC or
‧	contained in the Prospectus and this application form;	HKSCC Nominees.
agree that neither HKSCC nor HKSCC Nominees shall be	‧	If you are applying through a designated CCASS Participant
‧	liable to you in any way;								(other than a CCASS Investor Participant): For Hong Kong
declare and represent that except for an application made in		Offer Shares credited to the stock account of your designated
	the capacity as a Qualifying Fosun International Shareholder		CCASS Participant (other than a CCASS Investor Participant),
	or a Qualifying Fosun Pharma H Shareholders under the		you can check the number of Hong Kong Offer Shares allotted
	Preferential Offering, this is the only application made and the	‧	to you with that CCASS Participant.
	only application intended by you to be made to benefit you or	If you are applying as a CCASS Investor Participant: The
	the person for whose benefit you are applying;				Company expects to publish the results of CCASS Investor
‧	understand that the Company and the Joint Representatives		Participants' applications together with the results of the Hong
		版
Sampleor incurred by the applicant or any other person or entity however
	will rely on your declarations and representations in deciding		Kong Public Offering in South China Morning Post (in English)
	whether or not to make any allotment of any of the Hong Kong		and Hong Kong Economic Times (in Chinese) on Tuesday, 24
	Offer Shares to you and that you may be prosecuted for making		S pt mb r 2019. You should check the announcement published
‧	a false declaration;									by the Company and report any discrepancies to HKSCC
(if the application is made for your own benefit) warrant that		b fore 5:00 p.m. on Tuesday, 24 September 2019 or such other
	no other application has been or will be made for your b n fit		date as shall be determined by HKSCC or HKSCC Nominees.
	on a WHITE or YELLOW Application Form or by giving		Imm diat ly after the credit of the Hong Kong Offer Shares to
	electronic application instructions to HKSCC or to the White		your stock account you can check your new account balance via
	Form eIPO Service Provider by you or by any one as your		the CCASS Phone System and CCASS Internet System (under
‧	agent or by any other person; and							the樣proc dures contained in HKSCC's "An Operating Guide
(if you are making the application as an agent for the benefit		for Investor Participants" in effect from time to time). HKSCC
	of another person) warrant that (i) no other	a	ication has		will also make available to you an activity statement showing
	been or will be made by you as agent for or for the benefit of		the number of Hong Kong Offer Shares credited to your stock
	that person or by that person or by any other	erson as agent		account.
	for that person on a WHITE or YELLOW A		lication Form	No receipt will be issued for application money paid. The Company
	or by giving electronic application instructions to HKSCC; and	will not issue temporary documents of title.
	(ii) you have due authority to sign the A	lication Form or give	Refund of your money
	electronic application instructions on behalf of that other person	If you do not receive any Hong Kong Offer Shares or if your
	as its agent.								application is accepted only in part, the Company will refund to you
D.	Power of attorney								your application monies (including the related 1% brokerage, 0.0027%
If	your applic tion is	de through	n	authorised	attorney, the	SFC transaction levy and 0.005% Stock Exchange trading fee) without
Company	nd the Joint	Represent tives	ay	accept	or reject your	interest. If the Offer Price is less than the maximum Offer Price, the
application	t their discretion,	nd on	ny conditions they think fit,	Company will refund to you the surplus application monies (including
including evidence of the		'						the related 1% brokerage, 0.0027% SFC transaction levy and 0.005%
ttorney s uthority.
Determin tion of Offer Price	nd Alloc tion of Hong Kong Offer	Stock Exchange trading fee) without interest.
The refund procedures are stated in the "H. Despatch/Collection of
hares
								Share Certificates/e-Refund Payment Institutions/Refund Cheque"
The Offer Price is expected to be fixed on or around Tuesday, 17
in the "How to Apply for Hong Kong Offer Shares and Reserved
eptember 2019. Applic nts re required to pay the maximum Offer
Shares" section of the Prospectus.
Price of HK$57.80 for each Hong Kong Offer Share together with
1% brokerage, 0.0027% FC transaction levy and 0.005% Stock	Effect of the Information You Give to Computershare Hong Kong
Exchange trading fee. If the Offer Price is not agreed among the	Investor Services Limited
Company and the Joint Representatives (for themselves and on behalf	Computershare Hong Kong Investor Services Limited and its
of the Underwriters) on or before Tuesday, 24 September 2019, the	related bodies' corporate, directors, officers, employees and agents
Global Offering will not proceed.						("Representatives") expressly disclaim and exclude to the maximum
Applications for Hong Kong Offer Shares will not be processed and	extent permitted by law any liability for any loss or damage suffered
no allotment of any Hong Kong Offer Shares will be made until the
application lists close.								caused relating in any way to, or connected with, any information
The Company expects to announce the final Offer Price, the indication	provided by or on behalf of the applicant on or in connection with this
of the level of interest in the International Offering, the level of	document or any services provided hereunder, or any other written
applications under the Hong Kong Public Offering and the Preferential	or oral communication provided by or on behalf of the applicant in
Offering and the basis of allocation of the Hong Kong Offer Shares	connection with this document or any services provided hereunder.
and the Reserved Shares on Tuesday, 24 September 2019 in South	This	includes, without	limitation,	any errors or omissions in such
China Morning Post (in English) and the Hong Kong Economic
information however caused, or the Representatives or any other
Times (in Chinese) and on the website of the Stock Exchange at
person or entity placing any reliance on such information or any
www.hkexnews.hkand the Company's website at www.henlius.com.
documentation, image, recording or reproduction of such information,
Results of	allocations and the	Hong	Kong Identity	Card/passport/
or its accuracy, completeness, currency or reliability.

如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售 股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投資者 戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

Shanghai Henlius Biotech, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

（於中華人民共和國註冊成立的股份有限公司）

全 球 發 售

申請條件		‧	確認 閣下知悉招股章程內有關全球發售的限制；
甲、 可提出申請的人士	‧ 同意本公司、有關人士及白表eIPO 服務供應商現時
	及日後均毋須對並非載於招股章程（及其任何補充文
1.	閣下及 閣下為其利益提出申請的人士必須年滿18 歲
	件）的任何資料及陳述負責；
	並有香港地址。
	‧	承諾及確認 閣下或	閣下為其利益提出申請的人士
2.	如	閣下為商號，申請須以個別成員名義提出。
	並無申請或接納或表示有意認購（亦不會申請或接納
3.	聯名申請人不得超過四名。
	或表示有意認購）國際發售的任何發售股份，也沒有
4.	如	閣下為法人團體，申請須經獲正式授權人員簽
	參與國際發售（惟根據優先發售申請預留股份除外）；
	署，並註明其所屬代表身份及蓋上公司印鑑。
	‧	同意在本公司、H 股證券登記處、收款銀行及有關人
5.	閣下必須身處美國境外，並非美籍人士（定義見S 規
	例）或屬S 規例第902 條第(h)(3) 段所述的人士，亦非		士提出要求時，向彼等披露其所要求提供有關 閣下
			版
	中國法人或自然人（惟合資格境內機構投資者除外）。		及 閣下為其利益提出申請的人士的個人資料；
	‧	若香港境外任何地方的法例適用於 閣下的申請，則
6.	除上市規則及聯交所發出的指引信或聯交所已授予的
	任何相關豁免批准外，下列人士概不得申請認購任何		同意及保證 閣下已遵守所有有關法例，且本公司及
		有關人士概不會因接納 閣下的購買要約，或 閣下
	香港發售股份：
		在招股章程及本申請表格所載的條款及條件項下的權
	‧	本公司及╱或其任何子公司股份的現有實益擁有
		利及責任所引致的任何行動，而違反香港境外的任何
		人；
			法例；
	‧	本公司及╱或其任何子公司的董事或行政總裁；
	‧	樣
	‧	上述任何人士的聯繫人；	同意 閣下的申請一經接納，即不得因無意的失實陳
		述而撤銷；
	‧	本公司關連人士或緊隨全球發售完成後成為本公
	‧	同意 閣下的申請受香港法例規管；
		司關連人士的人士；或	‧	聲明、保證及承諾：(i) 閣下明白香港發售股份不曾
	‧	已獲分配或已申請或表示有意申請國際發售的任
		何發售股份（根據優先發售申請預留股份除外）。		亦不會根據美國證券法登記；及(ii) 閣下及 閣下
			為其利益申請香港發售股份的人士均身處美國境外
乙、 如	閣下為代名人
	（定義見S 規例），或屬S 規例第902 條第(h)(3) 段所述
閣下作為代名人可提交超過一份香港發售股份申請，方法		的人士；
是：(i) 透過中央結算及交收系統（「中央結算系統」）向香	‧	保證 閣下提供的資料真實及準確；
港結算發出電子認購指示（如 閣下為中央結算系統參與	‧	同意接納所申請數目或根據申請分配予	閣下但數目
者）；或(ii) 使用白色或黃色申請表格以自身名義代表不同		較少的香港發售股份；
的實益擁有人提交超過一份申請。	‧	授權本公司將香港結算代理人的名稱列入本公司股東
丙、 填交本申請表格的效用		名冊，作為 閣下獲分配的任何香港發售股份的持有
	人，並授權本公司及╱或其代理將任何股票存入中
閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申請
	央結算系統及╱或以普通郵遞方式按申請所示地址
人，即各人共同及個別）代表 閣下本身，或作為 閣下代
	向 閣下或聯名申請的首名申請人發送任何退款支
其行事的每位人士的代理或代名人：
	票，郵誤風險由 閣下承擔，除非 閣下已符合招股
‧	承諾簽立所有相關文件，並指示及授權本公司及╱
	章程「如何申請香港發售股份及預留股份」一節「親身
	或聯席代表（或彼等的代理或代名人）（作為本公司
		領取」一段的條件親身領取退款支票；
	代理），為按照章程細則的規定將 閣下獲分配的任
	‧	同意獲配發的股份是以香港結算代理人的名義發行，
	何香港發售股份以香港 結算代理人的名義登記而代
	表	閣下簽立任何文件；		並直接存入中央結算系統，以便記存於	閣下的中央
		結算系統投資者戶口持有人股份戶口或	閣下的指定
‧
同意Sample遵守香港法例第622 章公司條例、香港法例第32
	章公司（清盤及雜項條文）條例及章程細則；		中央結算系統參與者股份戶口；
	‧	同意香港結算及香港結算代理人各自保留權利(1) 不
‧	確認	閣下已細閱招股章程及本申請表格所載的條款
	及條件以及申請程序，並同意受其約束；		接納以香港結算代理人名義發行的該等獲配發的任何
		或部分股份，或不接納該等獲配發的股份存入中央結
‧	確認	閣下已接獲及細閱招股章程，提出申請時也僅
	算系統；(2) 促使該等獲配發的股份從中央結算系統
	依據招股章程載列的資料及陳述，而除招股章程任何

補充文件外，不會依賴任何其他資料或陳述；	提取，並轉入	閣下名下，有關風險及費用概由 閣
下自行承擔；及(3) 促使該等獲配發的股份以 閣下

如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售 股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投資者 戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

	名義發行（或如屬聯名申請人，則以排名首位申請人	發售成為無條件而並無終止，股票成為有效的所有權證明）
	的名義發行），而在此情況下，會以普通郵遞方式將	將以香港結算代理人名義發出，並按 閣下在申請表格的
	該等獲配發股份的股票寄往 閣下在申請表格上所示	指示於二零一九年九月二十四日（星期二）或在特別情況下
	地址（郵誤風險概由 閣下自行承擔）或提供該等股票	由香港結算或香港結算代理人指定的任何其他日期直接存
	予	閣下領取；	入中央結算系統，記入 閣下的中央結算系統投資者戶口
‧	同意香港結算及香港結算代理人均可調整獲配發以香	持有人股份戶口或 閣下指定的中央結算系統參與者股份
	港結算代理人名義發行的股份數目；	戶口。
‧	同意香港結算及香港結算代理人對招股章程及本申請	‧	如	閣下透過中央結算系統投資者戶口持有人以外的
	表格未有載列的資料及陳述概不負責；		指定中央結算系統參與者提出申請：香港發售股份將
‧	同意香港結算及香港結算代理人概不以任何方式
	存入	閣下指定的中央結算系統參與者（非中央結算
	對	閣下負責；
		系統投資者戶口持有人）股份戶口， 閣下可向該中央
‧	聲明及表示除以合資格復星國際股東或合資格復星
	結算系統參與者查詢	閣下獲配發的香港發售股份數
	醫藥H 股股東身份根據優先發售所提交的申請外，此
		目。
	乃	閣下為本身或 閣下為其利益提出申請的人士提
	‧	如	閣下以中央結算系統投資者戶口持有人身份提出
	出及擬提出的唯一申請；		申請：本公司預期於二零一九年九月二十四日（星期
‧	明白本公司及聯席代表將依據 閣下的聲明及陳述而
	二）在《南華早報》（英文）及《香港經濟日報》（中文）刊
	決定是否向 閣下分配任何香港發售股份， 閣下如
		登中央結算系統投資者戶口持有人的申請結果及香港
	作出虛假聲明，可能會被檢控；
		公開發售的結果。 閣下應查閱本公司刊發的公告，
‧ （如本申請是為 閣下本身利益提出）保證 閣下或作
			版
	為	閣下代理的任何人士或任何其他人士不曾亦不會		如有任何資料不符，請於二零一九年九月二十四日
		（星期二）下午五時正或香港結算或香港結算代理人
	為	閣下利益而以白色或黃色申請表格或向香港結算
		釐定的任何其他日期前知會香港結算。在香港發售股
	或向白表eIPO 服務供應商發出電子認購指示而提出
	其他申請；及		份存入 閣下的股份戶口後， 閣下即可透過「結算
‧ （如	閣下作為代理為另一人士的利益提出申請）保證		通」電話系統及中央結算系統互聯網系統（根據香港
	(i)	閣下（作為代理或為該人士利益）或該人士或任何		結算不時生效的「投資者戶口操作簡介」所載程序）查
	其他作為該人士代理的人士不曾亦不會以白色或黃色		詢	閣下的新戶口結餘。香港結算亦將向 閣下提供
	申請表格或向香港結算發出電子認購指示而提出其他		樣
		一份活動結單，列出存入 閣下股份戶口的香港發售
	申請；及(ii) 閣下獲正式授權作為該人士的代理代		股份數目。
	為簽署本申請表格或發出電子認購指示。	本公司不會就申請時繳付的款項發出收據，亦不會發出臨
丁、 授權書	時所有權文件。
如	閣下透過授權人士提出申請，本公司及聯席代表可按	退回款項
其認為合適的條件（包括出示獲授權證明）酌情接納或拒	若	閣下未獲分配任何香港發售股份或申請僅部分獲接
絕	閣下的申請。	納，本公司將不計利息退回	閣下的申請股款（包括相關的
釐定發售價及香港發售股份的分配	1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯交所
預期發售價於二零一九年九月十七日（星期二）或前後釐	交易費）。如發售價低於最高發售價，本公司將不計利息退
定。申請人須繳付每股香港發售股份57.80 港元的最高	回多收申請股款（包括相關的1% 經紀佣金、0.0027% 證監
發售價，另加1% 經紀佣金、0.0027% 證監會交易徵費及	會交易徵費及0.005% 聯交所交易費）。
0.005% 聯交所交易費。倘若本公司與聯席代表（為其自身	有關退款程序載於招股章程「如何申請香港發售股份及預
及代表包銷商）並無於二零一九年九月二十四日（星期二）或	留股份」一節「H. 發送╱領取股票╱電子退款指示╱退款支
之前協定發售價，全球發售將不會進行。	票」一段。
截止登記認購申請前，概不處理香港發售股份的申請或配	閣下提供給香港中央證券登記有限公司的資訊的有關影響
發任何香港發售股份。
香港中央證券登記有限公司和其有關連的法人團體、董
本公司預期於二零一九年九月二十四日（星期二）在《南
事、高級人員、僱員及代理人（「代表」）在法律所容許的最
華早報》（英文）、《香港經濟日報》（中文）、聯交所網站
大限度內明確卸棄及免除在任何方面與申請人或代表申請
(www.hkexnews.hk) 及本公司網站(www.henlius.com) 公
人在此文件提供的或與此文件或在此文件下提供的任何服
佈最終發售價、國際發售踴躍程度、香港公開發售及優
務相關的任何資料，或任何申請人或代表申請人提供與此
先發售認購申請數目以及香港發售股份及預留股份分配基
	Sample
準。香港公開發售及優先發售項下分配結果以及獲接納申	文件或在此文件下提供的任何服務相關的任何其它書面或
口頭通訊，有關或相關由申請人或任何其他人士或實體所
請人的香港身份證╱護照╱香港商業登記號碼（如適用）亦
同於上述網站公佈。	遭受或招致不論如何造成的任何損失或損害的任何法律責
如	閣下成功申請認購香港發售股份（全部或部分）	任。此包括，但不限於，該等資料中不論如何造成的任何
錯誤或遺漏，或代表或任何其他人士或實體對該等資料或
如	閣下的申請全部或部分獲接納， 閣下的股票（前提是
任何該等資料的文件記錄、影像、記錄或複製品作出的任

到二零一九年九月二十五日（星期三）上午八時正香港公開 何依據，或其準確性、完整性、合時性或可靠性。

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited ("HKSCC Nominees") and deposited directly into the Central Clearing and Settlement System ("CCASS") for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

Personal Data

H Share Registrar to discharge their obligations to

Personal Information Collection Statement

securities' holders and/or regulators and/or any other

purposes to which the securities' holders may from

This Personal Information Collection Statement informs

time to time agree.

the applicant for, and holder of, Hong Kong Offer Shares,

of the policies and practices of the Company and its

3. Transfer of personal data

H Share Registrar in relation to personal data and the

Personal data held by

the Company and its H Share

Personal Data (Privacy) Ordinance (Chapter 486 of the

版

Registrar relating to the securities holders will be kept

Laws of Hong Kong) (the "Ordinance").

confidential but the Company and its H Share Registrar

1.

Reasons for the collection of your personal data

may, to the extent necessary for achieving any of the

It is necessary for applicants and registered holders of

above purposes, disclose, obtain or transfer (whether

securities to supply correct personal data to the Company

within or outside Hong Kong) the personal data to, from

or its agents and the H Share Registrar when applying

or with any of the following:

for securities or transferring securities into or out of

•

'

the Company s appointed agents such as financial

their names or in procuring the services of the H Share

advisers, receiving bankers and overseas principal

Registrar.

share registrar;

Failure to supply the requested data may result in your

‧ where applicants for securities request a deposit into

application for securities being rejected, or

in delay or

CCASS, HKSCC or HKSCC Nominees, who will

use the personal data for the purposes of operating

the inability of the Company or its H Share Registrar to

CCASS;

effect transfers or otherwise render their services. It may

Sample

also prevent or delay registration or transfers of the Hong

‧

any agents, contractors or third-party service providers

Kong Offer Shares which you have successfully appli d

who off r administrative, telecommunications,

for and/or the dispatch of Share certificate(s) and/or

comput r, payment or other services to the Company

refund cheque(s) to which you are entitled.

H Share Registrar in connection with their respective

It is important that securities holders inform the

busin ss operation;

‧ the Stock Exchange, the SFC and any other statutory

Company and the H Share Registrar immediate y of any

r gulatory or governmental bodies or otherwise as

inaccuracies in the personal data supplied.

r 樣quir d by laws, rules or regulations; and

2.

Purposes

‧ any persons or institutions with which the securities'

The personal data of the securities holders may be used,

holders have or propose to have dealings, such as

held, processed, and/or stored (by whatever means) for

their bankers, solicitors, accountants or stockbrokers

the following purposes:

etc.

‧

processing

your

application

and

refund cheque,

4.

Retention of personal data

where applicable,

verification

of

co

liance with

The Company and its H Share Registrar will keep the

the terms and application procedures set out in

personal data of the applicants and holders of securities

this Application Form and the Prospectus and

announcing results of allocation of the Hong Kong

for as long as necessary to fulfil the purposes for which

Offer Sh res;

the personal data were collected. Personal data which

‧

compli nce with

pplic ble l ws and regulations in

is no longer required will be destroyed or dealt with in

‧

Hong Kong

nd elsewhere;

accordance with the Ordinance.

registering

new

issues or

tr nsfers into or

out of

5.

Access to and correction of personal data

the n mes

of securities'

holders

including,

where

Securities holders have the right to ascertain whether the

applic ble, HK

CC Nominees;

Company or the H Share Registrar hold their personal

‧ maintaining

or

updating the register of securities'

data,

to obtain a copy

of that data, and to correct any

holders of the Company;

data that is inaccurate. The Company and the H Share

‧ verifying securities holders' identities;

Registrar have the right to charge a reasonable fee for the

‧ establishing benefit entitlements of

securities'

processing of such requests.

holders of the Company, such as dividends, rights

‧

issues, bonus issues, etc.;

All requests for access to data or correction of data should

distributing communications from the Company and

be addressed to us, at our registered address disclosed in

‧

its subsidiaries;

the "Corporate Information" section of the Prospectus

compiling statistical information and securities'

or as notified from time to time, for the attention of the

‧

holders profiles;

company secretary, or our H Share Registrar for the

disclosing relevant information to facilitate claims on

attention of the privacy compliance officer.

entitlements; and

By signing an Application Form or by giving electronic

‧ any other incidental or associated purposes relating

to the above and/or to enable the Company and the

application instructions to HKSCC, you agree to all of

the above.

如 閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售 股份，並直接存入中央結算及交收系統（「中央結算系統」），以記存於 閣下的中央結算系統投資者 戶口持有人股份戶口或 閣下指定的中央結算系統參與者股份戶口，請使用本表格

個人資料	持有人及╱或監管機構承擔的責任及╱或證
個人資料收集聲明	券持有人不時同意的任何其他目的。
此項個人資料收集聲明是向香港發售股份的申請	3. 轉交個人資料
人和持有人說明有關本公司及其H 股證券登記處	本公司及其H 股證券登記處所持有關證券持有人
有關個人資料和香港法例第486 章《個人資料（私	的個人資料將會保密，但本公司及其H 股證券登
隱）條例》（「條例」）方面的政策和慣例。	記處可以在為達到上述任何目的之必要情況下，
1. 收集 閣下個人資料的原因	向下列任何人士披露，獲取或轉交（無論在香港
境內或境外）有關個人資料：
證券申請人及登記持有人以本身名義申請證券或
‧ 本公司委任的代理人，例如財務顧問、收款
轉讓或受讓證券時或尋求H 股證券登記處的服務
	樣
時，必須向本公司或其代理人及H 股證券登記處	銀行和主要海外股份過戶登記分處；
提供準確個人資料。	‧ （如證券申請人要求將證券存於中央結算系
未能提供所要求的資料可能導致 閣下申請證券	統）香港結算或香港結算代理人；彼等將會
	就中央結算系統的運作使用有關個人資料；
被拒或延遲，或本公司或其H 股證券登記處無法	‧ 向本公司或H 股證券登記處提供與其各自業版
落實轉讓或提供服務。此舉也可能妨礙或延遲登	務營運有關的行政、電訊、電腦、付款或其
記或轉讓 閣下成功申請的香港發售股份及╱或
他服務的任何代理人、承包商或第三方服務
寄發 閣下應得的股票及╱或退款支票。
供應商；
證券持有人所提供的個人資料如有任何錯誤，須
‧ 聯交所、證監會及任何其他法定監管機關或
立即通知本公司及H 股證券登記處。	政府部門或遵照其他法例、規則或法規；及
2. 目的	‧ 證券持有人與其進行或擬進行交易的任何人
證券持有人的個人資料可被採用及以任何方式持	士或機構，例如彼等的銀行、律師、會計師
有、處理及╱或保存，以作下列用途：	或股票經紀等。
‧ 處理 閣下的申請及退款支票（如適用）、核	4. 個人資料的保留
實是否符合本申請表格及招股章程載列的條	本公司及其H 股證券登記處將按收集個人資料所
款和申請程序以及公佈香港發售股份的分配	需的用途保留證券申請人及持有人的個人資料。
結果；	無需保留的個人資料將會根據條例銷毀或處理。
‧ 遵守香港及其他地區的適用法律及法規；	5. 查閱和更正個人資料
‧ 以證券持有人（包括香港結算代理人（如適
用））的名義登記新發行證券或轉讓或受讓證	證券持有人有權確定本公司或H 股證券登記處是
否持有其個人資料，並有權索取有關該資料的副
券；
本並更正任何不準確資料。本公司和H 股證券登
‧ 存置或更新本公司證券持有人的名冊；
記處有權就處理任何查閱資料的要求收取合理費
‧ 核實證券持有人的身份；
用。
‧ 確定本公司證券持有人的受益權利，例如股
所有查閱資料或更正資料的要求應按招股章程
息、供股和紅股等；
Sample「公司資料」一節所披露或不時通知的本公司註冊
‧ 分發本公司及其附屬公司的通訊；	地址送交公司秘書，或向本公司的H 股證券登記
‧ 編製統計數據和證券持有人資料；
處的個人資料私隱事務主任提出。
‧ 披露有關資料以便就權益索償；及
‧ 與上述有關的任何其他附帶或相關目的及╱	閣下簽署申請表格或向香港結算發出電子認購指
或使本公司及H 股證券登記處能履行對證券	示，即表示同意上述各項。